Sponsors
Referred to the House Committee on Armed Services.
Creates a five-year TRICARE pilot to give certain active-duty service members continuous glucose monitoring (CGM) devices and study whether real‑time metabolic tracking improves health and force readiness. The pilot requires participation for members identified as Partially Medically Ready or Not Medically Ready, limits how collected health data may be used (and forbids nongovernmental vendors from retaining or reusing the data beyond allowed purposes), requires training and education for participants and providers, and mandates reports to the Comptroller General and the Department of Defense on program results and implementation.
The Secretary of Defense shall carry out a pilot program under the TRICARE program to provide covered members with continuous glucose monitoring technology to assess effects of real-time metabolic health tracking and early intervention on improving member health and force readiness.
The Secretary shall require a covered member to participate in the pilot if the member is in the Partially Medically Ready or Not Medically Ready category of the Individual Medical Readiness program.
Health information collected under the pilot may be used only to carry out the pilot (including furnishing information to the Comptroller General), to provide health care (including preventive care) pursuant to title 10, and to conduct the Individual Medical Readiness program.
The Secretary may not use health information collected under the pilot to separate or discharge a member from the Armed Forces under title 10 (chapter 61).
A nongovernmental entity that provides CGM technology or services under the pilot may not retain any rights to health information collected, may not use such information except as authorized by this section, and may not retain such information after authorized use is completed.
Who is affected and how:
Active‑duty service members (direct): Members classified as Partially Medically Ready or Not Medically Ready will receive CGM devices and must participate; they may see improved medical monitoring, potential health benefits (better glucose control, earlier detection of metabolic issues), and requirements to follow study protocols.
Military medical personnel and TRICARE administrators (implementation): Medical staff must manage device distribution, training, data collection, clinical follow‑up, and integration of CGM data into medical records and readiness assessments. TRICARE will administer benefits for the pilot and oversee vendor relationships.
Department of Defense leadership and readiness managers (policy/operations): Will receive evidence on whether CGM use affects individual health and unit readiness, informing decisions about future scaling of the technology and clinical guidelines.
Vendors and device suppliers (operations & compliance): Companies supplying CGMs will provide devices and likely technical support but will be restricted from retaining or repurposing participant health data beyond permitted uses; contracts must reflect privacy and data‑use limitations.
Oversight bodies (Comptroller General/GAO): Required to evaluate and report on program performance, implementation, and outcomes, creating transparency and accountability.
Potential benefits:
Potential downsides and risks:
Overall effect:
Last progress June 5, 2025 (8 months ago)
Introduced on June 5, 2025 by Vernon G. Buchanan